Nov 09, 2017 21:04 pm UTC| Business
CHICAGO, Nov. 09, 2017 -- CHICAGO – Navy Pier, Chicago’s mission-driven cultural district, held its first-ever fundraising event, “A Celebration ExPIERience,” securing more than $1.7 million in funds to directly support...
Yield10 Bioscience Announces Third Quarter 2017 Financial Results
Nov 09, 2017 21:03 pm UTC| Business
WOBURN, Mass., Nov. 09, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three and nine months ended September 30, 2017. “Over the course of 2017 we have focused on generating...
CareDx Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:02 pm UTC| Business
BRISBANE, Calif., Nov. 09, 2017 -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...
Air Lease Corporation Announces Third Quarter 2017 Results
Nov 09, 2017 21:01 pm UTC| Business
LOS ANGELES, Nov. 09, 2017 -- Air Lease Corporation (ALC) (NYSE:AL) announces financial results for the three and nine months ended September 30, 2017. Revenues: $377 million for the three months ended September 30,...
STRATA Skin Sciences Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
Conference call and webcast, today at 4:30 pm Eastern Time HORSHAM, Pa., Nov. 09, 2017 -- (NASDAQ:SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated...
FutureFuel Releases Third Quarter and Nine-Month 2017 Results
Nov 09, 2017 21:01 pm UTC| Business
FutureFuel Third Quarter Net Income of $3.3 Million Reports Net Income of $3.3 Million or $0.08 per Diluted Share, and Adjusted EBITDA of $9.6 Million CLAYTON, Mo., Nov. 09, 2017 -- FutureFuel Corp. (NYSE:FF)...
Bio-Path Holdings Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:01 pm UTC| Business
HOUSTON, Nov. 09, 2017 -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update